plasmodium malariae
Unfortunately, over the years and due partly to incorrect use of the drugs in the field, resistance to antimalarial drugs has appeared, making certain treatments ineffective, fortunately, new molecules have been discovered and developed by researchers and the pharmaceutical industry.
The choice of treatment is based on the frequency of this resistance in the relevant area, and on the extent of any undesirable side effects caused by certain antimalarial drugs, to prevent the emergence of resistance to the most recent antimalarial drugs which are therefore the most powerful, the WHO in collaboration with the pharmaceutical industry, is actively examining the advantages of associating several antimalarial drugs that have different mechanisms of action and rapidity of action.
plasmodium malariae
Impact Malaria: paludisme, information for the public and healthcare professionals - plasmodium falciparum, malaria africa.
The difficulty of the clinical atypical form and biological pauci-parasitic form diagnosis, among patients who have followed a chemoprophylaxis treatment, means sometimes hospitalization and a multiplication of the diagnostic examinations, the presumptive treatment still remains a necessity at times.
In endemic zones, more especially in Africa, the treatment is given following a clinical diagnosis, where the major symptom is a fever, if it is completely justified, this presumptive treatment of a febrile crisis does not provide a fully satisfactory solution.
This attitude leads to the prescription of unjustified treatments for non-malarial fevers and increases the medicinal pressure exercised on the parasite, furthermore, the chemoresistance of Plasmodium falciparum imposes therapeutic choices with less well-tolerated and much more expensive molecules than chloroquine.
Resistance to these new molecules may also develop rapidly, if they are not used judiciously, only evidence of the parasite may provide a sure diagnosis and lead to appropriate treatment..
\'Malaria is the most important and the most widespread of the transmissible diseases, it threatens almost one third of Humanity, affects around 600 million people and is responsible, each year, for more than 2 million deaths, caused by microscopic parasites, Plasmodia, this disease is transmitted by the bite of certain mosquitoes, the Anopheles.
Its symptoms include bouts of a special type of fever, as well as an increase in the volume of the spleen and various other disorders, but malaria may involve complications such as cerebral attacks causing a fatal coma, especially among young children living in malaria-endemic areas or among expatriates and tourists.
Globally, malaria thrives in various inter-tropical regions, with the obvious exception of the desert areas or high mountains, beyond geographical or climatic factors, the frequency of the disease is essentially controlled by the mosquito vector.
An information database specially dedicated to healthcare professionals and general public, scientific news and events related to malaria, informations in real time about the fight against malaria, training tools for healthcare professionals.
Certain species are, in fact, more active than others, this explains the frequency and the intensity of the infection in inter-tropical Africa and in certain regions of the Amazon Basin.
plasmodium malariae